Clinical studies recruiting near Harbin

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Heilongjiang Provincial Hospital · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Harbin Medical University Cancer Hospital · Eli Lilly and Company · NCT07218380 Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283 A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
Phase 1 · Harbin Medical University Cancer Hospital · JiaRay Group · NCT06783569 A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer
Phase 2 · Affiliated Tumor Hospital of Harbin · CSPC Megalith Biopharmaceutical Co.,Ltd. · NCT07597629 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Harbin Medical University Cancer Hospital · Pfizer · NCT06758401 Indomethacin vs Diclofenac for Preventing PEP
NA · Harbin Medical University Affiliated Fourth Hospital · Air Force Military Medical University, China · NCT07071441 A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · Harbin Medical University Cancer Hospital /Id# 262070 · AbbVie · NCT06487559 PulseSelect™ PFA Global Registry
Phase N/A · The Second Affiliated Hospital of Harbin Medical University · Medtronic Cardiac Ablation Solutions · NCT06393920 China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Phase N/A · the First Affiliated Hospital of Harbin Medical University · Second Xiangya Hospital of Central South University · NCT05498974 A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Phase 2 · Harbin Medical University Cancer Hospital · Abbisko Therapeutics Co, Ltd · NCT06668103 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 Rectal NSAIDs With/Without PD Stent for PEP Prevention
NA · Harbin Medical University Affiliated Fourth Hospital · Air Force Military Medical University, China · NCT07117318 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Harbin Medical University Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Bactiseal Catheter Safety Registry Study
Phase N/A · the 2nd Affiliated Hospital of Harbin Medical University · Integra LifeSciences Corporation · NCT06276543 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Harbin Medical University Cancer Hospital · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0130 · Bristol-Myers Squibb · NCT07291076 The Chinese Familial Alzheimer's Network
Phase N/A · Capital Medical University · NCT03657732 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The Fourth Hospital of Harbin Medical University · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Heilongjiang Provincial Hospital · Eli Lilly and Company · NCT07415044 A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
Phase 1 · Harbin Medical University Cancer Hospital · Heronova Pharmaceuticals · NCT07071090 A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese
Phase 3 · The Second Affiliated Hospital of Harbin Medical University · Hoffmann-La Roche · NCT05562947 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · Harbin Medical University Cancer Hospital · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · Local Institution - 0003 · Bristol-Myers Squibb · NCT07361289 Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenoca
Phase 2 · Harbin Medical University Cancer Hospital · Jiangsu HengRui Medicine Co., Ltd. · NCT07102901 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Harbin Medical University Cancer Hospital · Eli Lilly and Company · NCT06890598 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · The Affiliated Tumor Hospital of Harbin Medical University · Turning Point Therapeutics, Inc. · NCT03093116 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectiou
Phase N/A · Heilongjiang Provincial Hospital · Huashan Hospital · NCT05965128 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Harbin Medical University Cancer Hospital · Pfizer · NCT07144280 Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safe
Phase N/A · The First Affiliated Hospital of Harbin Medical University · Institute of Hematology & Blood Diseases Hospital, China · NCT07185503

Look up another city

Look up another condition